 
<prompt> Trends in IPTp use by pregnant women | Percentage of women with a live birth in the 2 years before the survey who received at least 1, 2, or 3 doses of | (1+ doses, 2013 NDHS, 27) (2+ doses, 2013 NDHS, 17) (3+ doses, 2013 NDHS, 7) (1+ doses, 2015 NMIS, 51) (2+ doses, 2015 NMIS, 41) (3+ doses, 2015 NMIS, 21) (1+ doses, 2018 NDHS, 64) (2+ doses, 2018 NDHS, 40) (3+ doses, 2018 NDHS, 17) <response> The percentage of pregnant women who reported taking one or more doses of SP/Fansidar has increased since 2013, from 27% to 64%. There have also been increases in the percentage of women taking two or more doses (from 17% to 40%) and three or more doses (from 7% to 17%).  